Researchers have created a responsive hydrogel dressing that releases antibiotics on demand, aiming to speed healing while limiting unnecessary antibiotic exposure. The material is a water-rich hydrogel composed of long polymer chains held by chemical crosslinkers chosen to be sensitive to bacterial enzymes.
The team used a crosslinker that is cleaved by beta-lactamases, a class of enzymes produced by many harmful bacteria. In the presence of these enzymes the hydrogel degrades and releases its antibiotic cargo; in their absence the network remains intact and traps the drug, reducing unintended release and leaching.
Laboratory petri dish experiments showed the material degraded only with beta-lactamase–producing harmful bacteria and stayed intact with harmless strains. In mice, a single application fully eradicated a bacterial infection in an abrasion wound, and the hydrogel outperformed a commonly used antimicrobial dressing for both bacterial eradication and wound healing. The researchers reported reduced drug leaching and no promotion of antibiotic resistance during long-term exposure. The work, led by Anita Shukla and published in Science Advances, is patented and supported by the Dr. Ralph and Marian Falk Medical Research Trust. The team says the approach could conserve critical antibiotics and target infection control while minimizing unnecessary exposure; they note that more than 1 million people die each year from resistant infections and that number could near 10 million by 2050 if overuse continues.
Difficult words
- hydrogel — water-rich polymer material used as a wound dressing
- crosslinker — chemical that connects polymer chains together in materialcrosslinkers
- beta-lactamase — enzyme made by some bacteria that breaks antibioticsbeta-lactamases, beta-lactamase–producing
- degrade — to break down a material into smaller partsdegrades, degraded
- leach — to escape slowly from a material into surroundingsleaching
- eradicate — to completely eliminate a disease or unwanted organismeradicated, eradication
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How could an enzyme-responsive dressing change how antibiotics are used in hospitals or clinics?
- What benefits and risks should researchers and doctors consider before using this dressing on patients?
- How might the fact that the work is patented and supported by a medical research trust affect access and further development?
Related articles
Targeting Glut1 in Neutrophils Reduces Kidney Damage
Researchers using a mouse model of antibody-mediated glomerulonephritis found that neutrophils increase Glut1, a glucose transporter. Disabling Glut1 in neutrophils or using a Glut1 inhibitor reduced inflammation and improved kidney pathology in the model.
Emory study: 2023–24 COVID vaccine gives lasting antibodies
Emory University measured antibody responses in 24 people after the 2023–24 monovalent vaccine targeting Omicron XBB.1.5. The study found long-lasting antibodies, cross-reactive protection with the ancestral WA1 strain, and a 2.8-fold boost from immune imprinting.
High-dose antioxidants may harm sperm and offspring
A study in mice found that regular high doses of antioxidant supplements can damage sperm and change skull and facial development in offspring. Researchers advise caution for men taking large antioxidant doses when planning children.
